| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.007 |